See, for example, FujimuraJ.H., Crafting Science: A Sociohistory of the Quest for the Genetics of Cancer (Cambridge: Harvard University Press, 1996); and FriedmanJ.M., “Genetics and Epidemiology, Congenital Anomalies and Cancer,”American Journal of Human Genetics, 60 (1997): 469–73.
2.
See, for example, ScottW.K.Pericak-VanceM.A.HainesJ.L., Letter, “Genetic Analysis of Complex Diseases,”Science, 275 (1997): 1327; BellD.A.TaylorJ. A., Letter, “Genetic Analysis of Complex Diseases,”Science, 275 (1997): 1327–28; LongA.D.GroteM.N.LangleyC.H., Letter, “Genetic Analysis of Complex Diseases,”Science, 275 (1997): 1328; Muller-MyhsokB.AbelL., Letter, “Genetic Analysis of Complex Diseases,”Science, 275 (1997): 1328–29; MerikangasK., Letter, “Genetic Analysis of Complex Diseases,”Science, 275 (1997): 1329–30; RischN.MerikangasK., “The Future of Genetic Studies of Complex Human Diseases,”Science, 273 (1996): 1516–17; and SawcerS.GoodfellowP.N.CompstonA., “The Genetic Analysis of Multiple Sclerosis,”Trends in Genetics, 13 (1997): 234–39.
3.
See SpielmanR.S.McGinnisR.E.EwensW.J., “Transmission Test for Linkage Disequilibrium: The Insulin Gene Region and Insulin-Dependent Diabetes Mellitus (IDDM),”American journal of Human Genetics, 52 (1993): 506–11; and MitchellL.E., “Differentiating Between Fetal and Maternal Genotypic Effects Using the Transmission Test for Linkage Disequilibrium,”American Journal of Human Genetics, 60 (1997): 1006–07.
4.
See SawcerGoodfellowCompston, supra note 2.
5.
See, for example, Kent-FirstM., “A Lesson from Mosaics: Don't Leave the Genetics Out of Molecular Genetics,”Journal of NIH Research, 9 (1997): 29–33; IaroviciD., “Anti-Integrin Blocks Osteoporosis in Rats Lacking Estrogen,”Journal of NIH Research, 9 (1997): 34–35; and BoehmerA.L.M., “Germ-Line and Somatic Mosaicism in the Androgen Insensitivity Syndrome: Implications for Genetic Counseling,”American Journal of Human Genetics, 60 (1997): 1003–06.
6.
See CrystalR.G., “Transfer of Genes to Humans: Early Lessons and Obstacles to Success,”Science, 270 (1995): 404–10.
7.
See KoehnR.K.HilbishT.J., “The Adaptive Importance of Genetic Variation,”American Scientist, 75 (1996): 182–89.
8.
See LittleP., “Human Genetics. Woman's Meat, a Man's Poison,”Nature, 382 (1996): 494–95; and PostS.G., “The Clinical Introduction of Genetic Testing for Alzheimer Disease. An Ethical Perspective,”JAMA, 277 (1997): 832–36.
9.
See GiardielloF.M., “The Use and Interpretation of Commercial APC Gene Testing for Familial Adenomatous Polyposis,”N. Engl. J. Med., 336 (1997): 823–27.
10.
See NeelJ., “A Program for Genetics in a World of Desperate Scarcities,” in MatternM., ed., Moral Education V (Cold Spring Harbor: Cold Spring Harbor Press, 1995): 45–73; LeonardH.B.ZeckhauserR.J., “Cost-Benefit Analysis Applied to Risks: Its Philosophy and Legitimacy,” in BeauchampT.L.WaltersL., eds., Contemporary Issues in Bioethics (Belmont: Wadsworth, 3rd ed., 1989): 607–18; ModellB.KulievA.M., “A Scientific Basis for Cost-Benefit Analysis of Genetic Services,”Trends in Genetics, 9 (1993): 46–51; HidlebaughD.A.ThompsonI.E.BergerM.J., “Cost of Assisted Reproductive Technologies for a Health Maintenance Organization,”Journal of Reproductive Medicine, 42 (1997): 570–74; and DavisD.S., “Genetic Dilemmas and the Child's Right to an Open Future,”Rutgers Law Journal, 28 (1997): 549–92.
11.
See VerlinskyY., Abstract, “Preimplantation Diagnosis of Age-Related Aneuploidies by First and Second Polar Body FISH Analysis,”Journal of Assisted Reproduction and Genetics, 14 (1997): 477.
12.
See ScriverC.R., eds., The Metabolic and Inherited Bases of Inherited Disease (New York: McGraw-Hill, 7th ed., 1995); and WelshM.J., “Cystic Fibrosis,” in Scriver, id. at 3799–876.
13.
See SandersJ.S.PryorT.D.WedelM.K., “Prolonged Survival in an Adult with Cystic Fibrosis,”Chest, 11 (1980): 226–27.
14.
See GibsonL.E.CookeR.E., “A Test for Concentration of Electrolytes in Sweat in Cystic Fibrosis of the Pancreas Utilizing Pilocarpine by Iontophoresis,”Pediatrics, 23 (1959): 545.
15.
See CollinsF.S., “Cystic Fibrosis: Molecular Biology and Therapeutic Implications,”Science, 256 (1992): 774–83.
16.
See GravelR.A., “The GM2 Gangliosidoses,” in Scriver, supra note 12, at 2838–78.
17.
See id. at 2859.
18.
See id. at 2862.
19.
WortonR.G.BrookeM.H., “The X-Linked Muscular Dystrophies,” in Scriver, supra note 12, at 4195–226.
20.
GussoniE.BlauH.M.KingL.M., “The Fate of Individual Myoblasts after Transplantation into Muscles of DMD Patients,”Nature Medicine, 3 (1997): 970–77.
21.
EmeryA.E.H., Duchenne Muscular Dystrophy (New York: Oxford University Press, 2nd ed., 1993).
22.
See GussoniBlauKing, supra note 20.
23.
See CaskeyC.T., “Triplet Repeat Mutations in Human Disease,”Science, 256 (1992): 784–88; and SutherlandG.R.MolleyJ.C.RichardsR.I., “Fragile X Syndrome: The Most Common Cause of Familial Intellectual Handicap,”Medical Journal of Australia, 158 (1993): 482–85.
24.
See BeaudetA.L., “Genetics, Biochemistry, and Molecular Basis of Variant Human Phenotypes,” in Scriver, supra note 12, at 67.
25.
See Caskey, supra note 23.
26.
See id.
27.
See Beaudet, supra note 24; and EpsteinC., “Down Syndrome (Trisomy 21),” in Scriver, supra note 12, at 749–94.
28.
See WarburtonD., “Cytogenetic Abnormalities in Spontaneous Abortions of Recognized Conceptions,” in PorterI.H.WilleyA., eds., Perinatal Genetics: Diagnosis and Treatment (New York: Academic Press, 1986): 133–48.
29.
See ThompsonJ.S.ThompsonM.W., eds., Genetics in Medicine (Philadelphia: W.S. Saunders, 1986); and Beaudet, supra note 24.
30.
For a very comprehensive view of genetic diseases, see Metabolic and Molecular Bases of Inherited Disease. See Scriver, supra note 12.
31.
See ScriverC.R., “The Frequency of Genetic Disease and Congenital Malformation among Patients in a Pediatric Hospital,”Canadian Medical Association Journal, 108 (1973): 1111–15; BairdP.A., “Genetic Disorders in Children and Young Adults: A Population Study,”American Journal of Human Genetics, 42 (1988): 677–93; GaljaardH., Genetic Metabolic Diseases: Early Diagnosis and Prenatal Analysis (Amsterdam: Elsevier, 1980); DelhantyJ.D.A.HandysideA.H., “The Origin of Genetic Defects in the Human and their Detection in the Preimplantation Embryo,”Human Reproduction Update, 1 (1995): 201–15; and McKusickV.A., Mendelian Inheritance in Man (Baltimore: Johns Hopkins Press, 1992).
32.
See Beaudet, supra note 24, at 67; and see Galjaard, supra note 31.
33.
See DelhantyHandyside, supra note 31.
34.
See WilcoxJ.A., “Incidence of Early Loss of Pregnancy,”N. Engl. J. Med., 319 (1988): 189–94.
35.
See Beaudet, supra note 24, at 69.
36.
See SaikiR.K., “Primer-Directed Enzymatic Amplification of DNA with a Thermostabile DNA Polymerase,”Science, 239 (1988): 487–91.
37.
See DelhantyJ.D.A., “Multicolor FISH Detects Frequent Chromosomal Mosaicism and Chaotic Division in Normal Preimplantation Embryos from Fertile Patients,”Human Genetics, 99 (1997): 755–60.
38.
See MunnéS., “The Use of First Polar Bodies for Preimplantation Diagnosis of Aneuploidy,”Human Reproduction, 10 (1995): 1014–20; and DybanA., “Detection of Aneuploidy in Human Oocytes and Corresponding First Polar Bodies by Fluorescent In Situ Hybridization,”Journal of Assisted Reproduction and Genetics, 13 (1996): 73–78.
39.
See HandysideA.H.DelhantyJ.D.A., “Preimplantation Genetic Diagnosis: Strategies and Surprises,”Trends in Genetics, 13 (1997): 270–75.
40.
See McClureM.E., “The ART of Medically-Assisted Reproduction: An Embryo is an Embryo is an Embryo,” in ThomasmaD.C.KushnerT., eds., Birth to Death: Science and Bioethics (New York: Cambridge University Press, 1996): 35–49.
41.
See HardyK., “Human Preimplantation Development In Vitro Is Not Adversely Affected by Biopsy at the 8-Cell Stage,”Human Reproduction, 5 (1990): 708–14; PierceK.E., “Preimplantation Development of Mouse and Human Embryos Biopsied at Cleavage Stages Using a Modified Displacement Technique,”Human Reproduction, 12 (1997): 351–56.
42.
See Delhanty, supra note 37.
43.
See HarrisJ.A.JamesL., “State-by-State Cost of Birth Defects—1992,”Teratology, 56 (1997): 11–12.
44.
See HandysideDelhanty, supra note 39.
45.
See El-HashemiteN.WellsD.DelhantyJ.D.A., Letter & Comment, “Preimplantation Genetic Diagnosis of Beta-Thalassaemia,”Lancet, 348 (1996): 620.
46.
See FindlayI., “Simultaneous DNA ‘Fingerprinting,’ Diagnosis of Sex and Single-Gene Defect Status from Single Cells,”Human Reproduction, 10 (1995): 1005–13; and FindlayI., Abstract, “Fluorescent PCR in Single Cells,”Journal of Assisted Reproduction and Genetics, 14 (1997): 439–40.
47.
See GrifoJ.A., Abstract, “Preimplantation Genetic Diagnosis of Marfan's Syndrome Using Single Cell PCR and Restriction Endonuclease Digestion,”Journal of Assisted Reproduction and Genetics, 14 (1997): 441.
48.
See RayP.F.HandysideA.H., “Increasing the Denaturation Temperature During the First Cycles of Amplification Reduces Allele Dropout from Single Cells for Preimplantation Genetic Diagnosis,”Molecular Human Reproduction, 2 (1996): 213–18.
49.
See HandysideDelhanty, supra note 39.
50.
See ZhangL., “Whole Genome Amplification from a Single Cell: Implications for Genetic Analysis,”Proceedings of the National Academy of Sciences, 89 (1992): 5847–51; and see DelhantyHandyside, supra note 31.
51.
See XuK.P., “Primer Extension Preamplification for Detection of Multiple Genetic Loci from Single Human Blastomeres,”Human Reproduction, 8 (1993): 2206–10.
52.
See HarperJ.C., “Identification of the Sex of Human Preimplantation Embryos in Two Hours Using an Improved Spreading Method and Fluorescent In-Situ Hybridization (FISH) Using Directly Labelled Probes,”Human Reproduction, 9 (1994): 721–24.
53.
See SpeicherM.R.Gwyn BallardS.WardD.C., “Karyotyping Human Chromosomes by Combinatorial Multi-Fluor FISH,”Nature Genetics, 12 (1996): 368–75; and WeierH.-U.G., Abstract, “Spectral Imaging in Preconception/Pre-implantation Genetic Diagnosis (PGD) of Aneuploidy: Multi-Color, Multi-Chromosome Screening of Single Cells,”journal of Assisted Reproduction and Genetics, 14 (1997): 479.
54.
See HandysideA.H., “Preimplantation Genetic Diagnosis Today,” in EdwardsR.G.BeardH.K.HowlesC.M., eds., Human Conception In Vitro, 1995 (Oxford: Oxford University Press, 1995): 139–51.
55.
See id.
56.
See Delhanty, supra note 37.
57.
See id.
58.
See Verlinsky, supra note 11.
59.
See Handyside, supra note 54.
60.
See CarsonS., presentation at “Introducing Innovations into Practice: Technical and Ethical Analyses of Preimplantation Genetic Diagnosis and Intracytoplasmic Sperm Injection Technologies”Bethesda, Maryland (June 19, 1992) (on file with authors); and HandysideA., presentation at “Introducing Innovations into Practice: Technical and Ethical Analyses of Preimplantation Genetic Diagnosis and Intracytoplasmic Sperm Injection Technologies”Bethesda, Maryland (June 19, 1992) (on file with authors).